These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9768661)

  • 1. Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis.
    Drake WM; Perry LA; Hinds CJ; Lowe DG; Reznek RH; Besser GM
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3542-4. PubMed ID: 9768661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor.
    Johnson TN; Canada TW
    Ann Pharmacother; 2007 Feb; 41(2):350-3. PubMed ID: 17213295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with SMS 201-995 of Cushing's syndrome caused by ectopic adrenocorticotropin secretion from a metastatic gastrin-secreting pancreatic islet cell carcinoma.
    Lamberts SW; Tilanus HW; Klooswijk AI; Bruining HA; van der Lely AJ; de Jong FH
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1080-3. PubMed ID: 2846625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.
    Schulte HM; Benker G; Reinwein D; Sippell WG; Allolio B
    J Clin Endocrinol Metab; 1990 May; 70(5):1426-30. PubMed ID: 2159485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome.
    Krakoff J; Koch CA; Calis KA; Alexander RH; Nieman LK
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4104-8. PubMed ID: 11549633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's syndrome.
    Allolio B; Schulte HM; Kaulen D; Reincke M; Jaursch-Hancke C; Winkelmann W
    Klin Wochenschr; 1988 Apr; 66(8):361-4. PubMed ID: 3392892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel use of etomidate for intentional adrenal suppression to control severe hypercortisolemia in childhood.
    Mettauer N; Brierley J
    Pediatr Crit Care Med; 2009 May; 10(3):e37-40. PubMed ID: 19433940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease.
    Chan LF; Vaidya M; Westphal B; Allgrove J; Martin L; Afshar F; Hindmarsh PC; Savage MO; Grossman AB; Storr HL
    Horm Res Paediatr; 2011; 75(6):441-6. PubMed ID: 21430362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma.
    Park SY; Rhee Y; Youn JC; Park YN; Lee S; Kim DM; Song SY; Lim SK
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):13-6. PubMed ID: 17286228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate.
    Heyn J; Geiger C; Hinske CL; Briegel J; Weis F
    Pituitary; 2012 Jun; 15(2):117-25. PubMed ID: 21556813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etomidate infusion at low doses is an effective and safe treatment for severe Cushing's syndrome outside intensive care.
    Constantinescu SM; Driessens N; Lefebvre A; Furnica RM; Corvilain B; Maiter D
    Eur J Endocrinol; 2020 Aug; 183(2):161-167. PubMed ID: 32449698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease.
    Greening JE; Brain CE; Perry LA; Mushtaq I; Sales Marques J; Grossman AB; Savage MO
    Horm Res; 2005; 64(3):140-3. PubMed ID: 16192738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hypercortisolism: a medical emergency requiring urgent intervention.
    Lutgers HL; Vergragt J; Dong PV; de Vries J; Dullaart RP; van den Berg G; Ligtenberg JJ
    Crit Care Med; 2010 Jul; 38(7):1598-601. PubMed ID: 20495451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Etomidate for the Management of Cushing's Syndrome Complicated by Pulmonary Nocardiosis.
    Hays WB; Czosnowski Q
    J Pharm Pract; 2022 Dec; 35(6):1057-1059. PubMed ID: 34056961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe psychosis due to ectopic Cushing's syndrome.
    Bilgin YM; van der Wiel HE; Fischer HR; De Herder WW
    J Endocrinol Invest; 2007 Oct; 30(9):776-9. PubMed ID: 17993771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's syndrome: a combined treatment with etomidate and osilodrostat in severe life-threatening hypercortisolemia.
    Dzialach L; Sobolewska J; Respondek W; Wojciechowska-Luzniak A; Witek P
    Hormones (Athens); 2022 Dec; 21(4):735-742. PubMed ID: 36129663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etomidate infusion in the critical care setting for suppressing the acute phase of Cushing's syndrome.
    Dabbagh A; Sa'adat N; Heidari Z
    Anesth Analg; 2009 Jan; 108(1):238-9. PubMed ID: 19095856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.